NKX2-4 and acute erythroid leukemia: NKX2-4 is aberrantly expressed in erythroblastic leukemia cell line OCI-M2 and represses FLI1, while NKX2-3 is aberrantly expressed in megakaryoblastic leukemia cell line ELF-153 and activates FLI1.